Spiriva 18 mcg, Kapseln zur Inhalation

7680558550092 CH-55855 Kapseln
Spiriva 18 mcg, Kapseln zur Inhalation
Spiriva 18 mcg, Kapseln zur Inhalation
Spiriva 18 mcg, Kapseln zur Inhalation
1 / 3
google

Article details

Package size
90
Selling units
90
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
07/07/2021
Summary of Product Characteristics
Français
07/07/2021
Summary of Product Characteristics
Italien
07/07/2021
Patient information leaflet
Allemand
04/02/2021
Patient information leaflet
Français
04/02/2021
Patient information leaflet
Italien
04/02/2021

Detailed composition

Substance Quantity Type Category
(N/A)
18.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 112.85
Specialties list
Yes
Generic
No
SL addition date: 01/05/2009

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
55855
Drug name
Spiriva, Kapseln zur Inhalation
Galenic form
KAHI
ATC Code
R03BB04
Authorization status
Z
Dispensing category
B
First authorization
16/12/2002
Authorization expiration date
31/12/9999
IT Number
03.04.3.
Domain
Human medicine
Field of application
Dauerbehandlung COPD

Package details

Description (FR)
SPIRIVA caps inh 18 mcg 90 pce
Description (DE)
SPIRIVA Inh Kaps 18 mcg 90 Stk
Market launch
16/12/2002
Narcotic (BTM)
No

Other package sizes (2)

SPIRIVA caps inh 18 mcg 30 pce
30 KAP
GTIN: 7680558550085
View
None
10 KAP
GTIN: None
Not in V1